2096:HKG
Simcere Pharmaceutical Group Ltd
11,02 HK$
arrow_upward
+1,75%(+0,19) 1K
16-okt, 16:08:14 (GMT+8) · HKD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto2096 tikeri uchun statistika yaratilmoqda...
Ochish
10,85 HK$
Yuqori
11,29 HK$
Past
10,85 HK$
Bozor kapitali
28,30 mlrd
Oʻrtacha hajm
4,02 mln
Hajmi
5,80 mln
Dividend
1,88%
Choraklik dividendlar
0,05 HK$
Eks-dividend sanasi
18-iyn, 2025
P/E koeffitsiyenti
16,54
52 haftalik eng yuqori
14,38 HK$
52 haftalik eng past
9,07 HK$
Aksiya boʻyicha daromad
0,67 HK$
Muomaladagi aksiyalar
2,57 mlrd
Xodimlar soni
7 ming
Ochish
10,85 HK$
Yuqori
11,29 HK$
Past
10,85 HK$
Bozor kapitali
28,30 mlrd
Oʻrtacha hajm
4,02 mln
Hajmi
5,80 mln
Dividend
1,88%
Choraklik dividendlar
0,05 HK$
Eks-dividend sanasi
18-iyn, 2025
P/E koeffitsiyenti
16,54
52 haftalik eng yuqori
14,38 HK$
52 haftalik eng past
9,07 HK$
Aksiya boʻyicha daromad
0,67 HK$
Muomaladagi aksiyalar
2,57 mlrd
Xodimlar soni
7 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
14 daqiqa oldin
Is Intellia Therapeutics (NTLA) Cheap Or Pricey On Its New Chief Medical Officer Appointment?
Capital Brief
·
38 daqiqa oldin
Australian shares to open lower as chip selloff weighs on Nasdaq
Yahoo Finance
·
12 soat oldin
Michael Burry Warns of a Stock Market ‘Supervolcano’
AOL.com
·
8 soat oldin
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Profil
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
Simcere Pharmaceutical Group Ltd haqida
CEORen Jinsheng
Xodimlar soni7,06 ming
Asos solingan1995
Bosh ofislarNanjing, Jiangsu, Xitoy
Sektor-
Veb-saytsimcere.com